Stockreport

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

Cabaletta Bio, Inc.  (CABA) 
PDF PHILADELPHIA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the fir [Read more]